Attached files
file | filename |
---|---|
EX-99.1 - GENTA INC DE/ | v168061_ex99-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT PURSUANT
TO
SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of report (Date of earliest event reported): December 2,
2009
|
||
GENTA
INCORPORATED
|
||
(Exact
Name of Registrant
as
Specified in Its Charter)
|
||
Delaware
|
||
(State
or Other Jurisdiction of Incorporation)
|
||
0-19635
|
33-0326866
|
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
|
200
Connell Drive
Berkeley
Heights, NJ
|
07922
|
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
|
(908)
286-9800
|
||
(Registrant’s
Telephone Number, Including Area Code)
|
||
(Former
Name or Former Address, if Changed Since Last
Report)
|
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the Registrant
under any
of the following provisions:
o Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
o Pre -commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d
-2(b))
o Pre -commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
8.01 Other Events.
On
December 2, 2009, Genta Incorporated, (the Company), announced that the Company
will supply Ganite® (gallium nitrate injection) for a new clinical trial that
will be initiated in patients with cystic fibrosis (CF) who may develop serious
infections.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits.
Exhibit
Number
|
Description
|
||
99.1
|
Press
Release of the Company dated December 2,
2009
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
GENTA
INCORPORATED
|
|||||
Date:
|
December
2, 2009
|
By:
|
/s/
GARY SIEGEL
|
||
Name:
|
Gary
Siegel
|
||||
Title:
|
Vice
President, Finance
|
EXHIBIT
INDEX
Exhibit
Number
|
Description
|
Sequentially
Numbered
Page
|
99.1
|
Press
Release of the Company dated December 2, 2009
|